Literature DB >> 11716141

Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranes.

G P Eckert1, W G Wood, W E Müller.   

Abstract

The effects of aging and of different amyloid beta-peptides (A beta) on the properties of purified synaptosomal plasma and mitochondrial membranes were studied using different fluorescent dyes. Aging led to opposite membrane alterations in both mouse brain fractions. Cholesterol levels were significantly enhanced in synaptosomal plasma membranes (SPM) from aged mice only. Flexibility of membrane fatty acids was decreased in synaptosomal plasma and mitochondrial membranes, mobility of pyrene was enhanced, but in SPM only. With regard to acyl chain flexibility in aged brain membranes, both membrane preparations were less sensitive to A beta. By contrast, effects of A beta on the mobility of pyrene were not reduced for aged synaptic membranes, but even seemed to be enhanced in the case of aged mitochondrial membranes. The data presented significantly enhance our understanding of the mechanism of the A beta's disordering effects on synaptosomal membranes that are also detectable for mitochondrial membranes and show for the first time that A beta effects are modified by brain aging. This is of special interest since membrane alterations and in particular modifications of membrane cholesterol were recently linked to Alzheimer's Disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716141     DOI: 10.1007/s007020170024

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  13 in total

1.  The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Authors:  Stephanie J Soscia; James E Kirby; Kevin J Washicosky; Stephanie M Tucker; Martin Ingelsson; Bradley Hyman; Mark A Burton; Lee E Goldstein; Scott Duong; Rudolph E Tanzi; Robert D Moir
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

2.  Reciprocal modulation between amyloid precursor protein and synaptic membrane cholesterol revealed by live cell imaging.

Authors:  Claire E DelBove; Claire E Strothman; Roman M Lazarenko; Hui Huang; Charles R Sanders; Qi Zhang
Journal:  Neurobiol Dis       Date:  2019-03-15       Impact factor: 5.996

3.  Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime.

Authors:  Janett Eckmann; Laura E Clemens; Schamim H Eckert; Stephanie Hagl; Libo Yu-Taeger; Thierry Bordet; Rebecca M Pruss; Walter E Muller; Kristina Leuner; Huu P Nguyen; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2014-03-18       Impact factor: 5.590

Review 4.  Alzheimer's disease and cholesterol: the fat connection.

Authors:  Laura Canevari; John B Clark
Journal:  Neurochem Res       Date:  2006-12-27       Impact factor: 3.996

Review 5.  Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria.

Authors:  Sebastian Schaffer; Heike Asseburg; Sabine Kuntz; Walter E Muller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2012-06-17       Impact factor: 5.590

6.  Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice.

Authors:  Gero P Hooff; W Gibson Wood; Ji-Hyun Kim; Urule Igbavboa; Wei-Yi Ong; Walter E Muller; Gunter P Eckert
Journal:  Mol Neurobiol       Date:  2012-06-13       Impact factor: 5.590

Review 7.  Cellular membrane fluidity in amyloid precursor protein processing.

Authors:  Xiaoguang Yang; Grace Y Sun; Gunter P Eckert; James C-M Lee
Journal:  Mol Neurobiol       Date:  2014-02-20       Impact factor: 5.590

8.  Aniracetam restores the effects of amyloid-beta protein or ageing on membrane fluidity and intracellular calcium concentration in mice synaptosomes.

Authors:  Y Li; J-J Wang; J-X Cai
Journal:  J Neural Transm (Vienna)       Date:  2007-06-08       Impact factor: 3.575

9.  The interaction of beta-amyloid protein with cellular membranes stimulates its own production.

Authors:  Imke Peters; Urule Igbavboa; Tanja Schütt; Schamim Haidari; Ulrike Hartig; Ximena Rosello; Steffi Böttner; Ekaterini Copanaki; Thomas Deller; Donat Kögel; W Gibson Wood; Walter E Müller; Gunter P Eckert
Journal:  Biochim Biophys Acta       Date:  2009-02-02

10.  No consistent bioenergetic defects in presynaptic nerve terminals isolated from mouse models of Alzheimer's disease.

Authors:  Sung W Choi; Akos A Gerencser; Ryan Ng; James M Flynn; Simon Melov; Steven R Danielson; Bradford W Gibson; David G Nicholls; Dale E Bredesen; Martin D Brand
Journal:  J Neurosci       Date:  2012-11-21       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.